rt-cgm dexcom g4 Search Results


rt cgm device  (Dexcom Inc)
86
Dexcom Inc rt cgm device
Rt Cgm Device, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g4/cgm+rt/pmc12580925-218-26-28
Average 86 stars, based on 1 article reviews
rt cgm device - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
g7 rt cgm systems  (Dexcom Inc)
86
Dexcom Inc g7 rt cgm systems
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
G7 Rt Cgm Systems, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g4/cgm+systems/pmc13012535-117-11-6
Average 86 stars, based on 1 article reviews
g7 rt cgm systems - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
factory calibrated cgm  (Dexcom Inc)
86
Dexcom Inc factory calibrated cgm
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Factory Calibrated Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g4/calibrated+cgm+dexcom+factory+g6/pmc12409212-215-41-46
Average 86 stars, based on 1 article reviews
factory calibrated cgm - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
dexcom g4  (Dexcom Inc)
86
Dexcom Inc dexcom g4
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Dexcom G4, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g4/dexcom+g4/pmc12846742-53-6-8
Average 86 stars, based on 1 article reviews
dexcom g4 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
older generation rtcgm systems  (Dexcom Inc)
86
Dexcom Inc older generation rtcgm systems
Net changes in non-insulin medication class count stratified by cohort <t>and</t> <t>RT-CGM</t> use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.
Older Generation Rtcgm Systems, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt-cgm+dexcom+g4/generation+older+rtcgm+systems/pm41309353-69-5-8
Average 86 stars, based on 1 article reviews
older generation rtcgm systems - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Net changes in non-insulin medication class count stratified by cohort and RT-CGM use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

doi: 10.2147/DMSO.S574769

Figure Lengend Snippet: Net changes in non-insulin medication class count stratified by cohort and RT-CGM use or CGM non-use. “Addition” and “Reduction” categories indicate a net increase or decrease in medications at follow-up compared to baseline. “No Change” indicates the same medication classes were used at baseline and follow-up. “Net Zero Change” indicates the same number of medication classes were added as removed at follow-up compared to baseline. Cohorts are presented as ( A ) T2D-NIT, ( B ) T2D-BIT, and ( C ) T2D-IIT.

Article Snippet: The RT-CGM group included individuals initiating Dexcom G4, G5, G6, or G7 RT-CGM systems, identified by National Drug Codes (NDCs; Supplementary Table 1 ), with the index date as the first RT-CGM claim.

Techniques: Medications

Proportion of each cohort achieving A1c targets stratified by RT-CGM use or CGM non-use. ( A ) Proportion of NIT cohort achieving A1c goals at follow-up, ( B ) Proportion of BIT cohort achieving A1c goals at follow-up, ( C ) Proportion of IIT cohort achieving A1c goals at follow-up, ( D and E ) Proportion of each cohort with a baseline A1c above the indicated target meeting the target at follow-up. **, p<0.001; ***, p<0.0001.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

doi: 10.2147/DMSO.S574769

Figure Lengend Snippet: Proportion of each cohort achieving A1c targets stratified by RT-CGM use or CGM non-use. ( A ) Proportion of NIT cohort achieving A1c goals at follow-up, ( B ) Proportion of BIT cohort achieving A1c goals at follow-up, ( C ) Proportion of IIT cohort achieving A1c goals at follow-up, ( D and E ) Proportion of each cohort with a baseline A1c above the indicated target meeting the target at follow-up. **, p<0.001; ***, p<0.0001.

Article Snippet: The RT-CGM group included individuals initiating Dexcom G4, G5, G6, or G7 RT-CGM systems, identified by National Drug Codes (NDCs; Supplementary Table 1 ), with the index date as the first RT-CGM claim.

Techniques: